Literature DB >> 6478639

Cholesterol ester storage disease in an adult presenting with sea-blue histiocytosis.

G T Besley, D M Broadhead, E Lawlor, S R McCann, J D Dempsey, M I Drury, J Crowe.   

Abstract

An adult patient is described with hepatomegaly and sea-blue histiocytes in the bone marrow. A diagnosis of cholesterol ester storage disease was established following enzyme and lipid analyses on liver biopsy and cultured skin fibroblasts. Acid esterase activity was deficient (approx. 5% of controls) in liver and fibroblasts using [14C]-triolein or 4-methylumbelliferyl palmitate as substrates. Cholesterol ester levels were raised about 70-fold in liver, whereas triglyceride levels were only marginally raised. Marked accumulation of cholesterol esters was also demonstrated in cultured fibroblasts. Clinically, the patient responded favourably to phenobarbitone treatment. However, this was not reflected in liver acid esterase or lipid levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478639     DOI: 10.1111/j.1399-0004.1984.tb04367.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult.

Authors:  Hemant Chatrath; Steven Keilin; Bashar M Attar
Journal:  Dig Dis Sci       Date:  2008-05-14       Impact factor: 3.199

Review 2.  Bone marrow cytological storage phenomena in lipidoses.

Authors:  S Ziyeh; K Harzer
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

3.  Very low levels of high density lipoprotein cholesterol in four sibs of a family with non-neuropathic Niemann-Pick disease and sea-blue histiocytosis.

Authors:  M B Viana; R Giugliani; V H Leite; M L Barth; C Lekhwani; C M Slade; A Fensom
Journal:  J Med Genet       Date:  1990-08       Impact factor: 6.318

4.  Molecular markers of brain cholesterol homeostasis are unchanged despite a smaller brain mass in a mouse model of cholesteryl ester storage disease.

Authors:  Amal A Aqul; Charina M Ramirez; Adam M Lopez; Dennis K Burns; Joyce J Repa; Stephen D Turley
Journal:  Lipids       Date:  2021-10-07       Impact factor: 1.880

5.  Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.

Authors:  Manisha Balwani; Catherine Breen; Gregory M Enns; Patrick B Deegan; Tomas Honzík; Simon Jones; John P Kane; Vera Malinova; Reena Sharma; Eveline O Stock; Vassili Valayannopoulos; J Edmond Wraith; Jennifer Burg; Stephen Eckert; Eugene Schneider; Anthony G Quinn
Journal:  Hepatology       Date:  2013-03-28       Impact factor: 17.425

6.  Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.

Authors:  Marie Marduel; Khadija Ouguerram; Valérie Serre; Dominique Bonnefont-Rousselot; Alice Marques-Pinheiro; Knut Erik Berge; Martine Devillers; Gérald Luc; Jean-Michel Lecerf; Laurent Tosolini; Danièle Erlich; Gina M Peloso; Nathan Stitziel; Patrick Nitchké; Jean-Philippe Jaïs; Marianne Abifadel; Sekar Kathiresan; Trond Paul Leren; Jean-Pierre Rabès; Catherine Boileau; Mathilde Varret
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.